A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge - Wikidata - awgldk - TriplyDB

A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge

A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge

http://www.wikidata.org/entity/Q35855727

about

Cedar virus: a novel Henipavirus isolated from Australian bats Henipavirus mediated membrane fusion, virus entry and targeted therapeutics Hendra virus Protective efficacy of passive immunization with monoclonal antibodies in animal models of H5N1 highly pathogenic avian influenza virus infection Converting monoclonal antibody-based immunotherapies from passive to active: bringing immune complexes into play Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies.Hendra virus and Nipah virus animal vaccines.Management of the slowly emerging zoonosis, Hendra virus, by private veterinarians in Queensland, Australia: a qualitative study.A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge.Expression sequence tag library derived from peripheral blood mononuclear cells of the chlorocebus sabaeus.Henipavirus infections: lessons from animal models.Potent inhibition of Hendra virus infection via RNA interference and poly I:C immune activation Rhabdovirus-based vaccine platforms against henipaviruses Crystal structure of the Hendra virus attachment G glycoprotein bound to a potent cross-reactive neutralizing human monoclonal antibody.Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections Henipavirus outbreaks to antivirals: the current status of potential therapeutics.A treatment for and vaccine against the deadly Hendra and Nipah viruses Single-dose live-attenuated vesicular stomatitis virus-based vaccine protects African green monkeys from Nipah virus disease.Immunization strategies against henipaviruses Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody.Leishmania tarentolae: an alternative approach to the production of monoclonal antibodies to treat emerging viral infections.7th annual European Antibody Congress 2011: November 29-December 1, 2011, Geneva, Switzerland.The immune response to Nipah virus infection.Escape From Monoclonal Antibody Neutralization Affects Henipavirus Fitness In Vitro and In Vivo.Receptor-binding domains of spike proteins of emerging or re-emerging viruses as targets for development of antiviral vaccines.Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins.Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy.Hendra virus vaccine, a one health approach to protecting horse, human, and environmental health.A recombinant Hendra virus G glycoprotein subunit vaccine protects nonhuman primates against Hendra virus challenge.Henipavirus receptor usage and tropism.Hendra virus: a one health tale of flying foxes, horses and humans.Human monoclonal antibodies as candidate therapeutics against emerging viruses and HIV-1.Henipavirus pathogenesis and antiviral approaches.Henipavirus Encephalitis: Recent Developments and Advances.Protection against henipavirus infection by use of recombinant adeno-associated virus-vector vaccines.Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody.Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies.Containing the contagion: treating the virus that inspired the film.Vaccination of ferrets with a recombinant G glycoprotein subunit vaccine provides protection against Nipah virus disease for over 12 months.Therapeutic antibodies and infectious diseases, Tours, France, November 20-22, 2012.

P2860

Q21090488-6CB6C7BB-A422-47B8-9A92-28E13A415067 Q27002511-22D829D3-F42A-4CCE-BA22-8423104F7148 Q27006568-80269B40-4BE6-4AA1-91A7-77A0563F6276 Q27324824-14E423FC-D888-41DC-87FE-6C051B6BD466 Q27468870-E056488D-872D-4854-96CF-3F0EE7A24FC0 Q30362113-4825E6ED-B236-4AF9-9D25-9D2CE9CF4E7B Q30387821-B366CEF5-0908-4A4D-9E51-95854E5F6BC1 Q34234758-1A7DF046-76A9-42BB-821F-F5AB98A7D7CA Q34292954-2A1D05B2-4DF0-4AC9-8ADC-58E3826EE60E Q34315105-5C9FCEC3-DCE3-4C12-ABDD-45610434F743 Q34533606-0B86C31C-4294-4418-BC8C-8B90582E8A19 Q34731475-3F3DCBF0-6543-40D3-B662-1F4F41FA2EC7 Q34992537-C3C1EF40-7567-4730-95FD-4DA363575747 Q35018061-5C6CC66B-5862-4A41-86B7-0B955789EB00 Q35019893-D14E28DF-0912-4D36-9A90-B3C5D366D706 Q35141580-4FFA52B4-4BD1-4F26-BFDA-72D5C949409A Q35565878-21C83F62-71D8-4D5A-BD56-6F144B52314F Q35613127-3B877D01-B004-4F51-A0C0-B4E21733D7C1 Q35735589-A0435713-A234-4399-9F72-6BDED534DCB4 Q35741723-93BCB99D-6CC2-4104-A58A-7B6367E38DD2 Q35863259-0271A39A-CF03-4FBA-A5B7-E7EDC3B8F6F1 Q35992488-5E56AAE3-B718-432B-9378-5013F396F9E0 Q36203198-79DC1A70-36FE-4FEF-A817-192192384C41 Q36440258-471EA1DC-D4A4-4C8C-A7FA-7BB4499017CD Q36779713-24B03988-3103-411F-A430-F50FA751CABA Q36791009-12A39EDE-167B-4C80-8DEC-4D3AF1724D5E Q37147843-7657634E-61D4-43B0-9E74-A61D43619D54 Q37621722-944B1200-ADC8-4A02-8895-9B2EB75425A0 Q37713970-51A80FE3-D599-49CB-BD94-9B22FE7086E3 Q38018531-38D8E035-16B0-4E31-B368-3156B012AF2F Q38093644-58AA0940-D753-41DA-8FB1-59029C7E95FC Q38098075-5FE491FB-1745-4E6D-B79B-BA97AFCB0629 Q38337204-1EF5AE0C-B689-415F-9897-585524CFB1D4 Q38567114-43F6E756-97DC-448F-820C-8279FCAEF7C5 Q39240212-5ACE37B1-6E01-4280-AD3F-3F450A8A3FCE Q40062330-519D9CB3-6BDC-4B9F-9D57-69D8F9F731DD Q40283373-90782470-F6D6-4FC5-BDB2-95D00307D214 Q42083225-F788B979-2DF6-418C-B5C6-1E4561F43971 Q42254569-285527CC-022F-4B1C-90EA-01F2F7F887CE Q42846265-C8C6CCEE-7FDC-4B16-8913-7AD81BC21995

P2860

A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge

http://www.wikidata.org/entity/Q35855727

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

A neutralizing human monoclona ...... ys from hendra virus challenge

@ast

A neutralizing human monoclona ...... ys from hendra virus challenge

@en

type

label

A neutralizing human monoclona ...... ys from hendra virus challenge

@ast

A neutralizing human monoclona ...... ys from hendra virus challenge

@en

prefLabel

A neutralizing human monoclona ...... ys from hendra virus challenge

@ast

A neutralizing human monoclona ...... ys from hendra virus challenge

@en

P1433

Q35855727-A0C7FE6C-7104-4450-9610-9D8524BFED69

P1476

Q35855727-88D9453F-2C80-4C43-B7F9-541B7BA19C9D

P2093

Q35855727-0A81B875-AC74-4106-B5A6-6C93329FF73D

Q35855727-12B0AC5C-48BE-480B-BE0A-E39DEE105B41

Q35855727-1A7C2F27-8126-400C-A07C-C1375A34974F

Q35855727-242FBBE4-836C-41C9-8EB4-BC42C29DE9C1

Q35855727-2711F33C-3456-405F-AAFB-FA640D68A51F

Q35855727-572C2D16-7DE3-474B-B503-3E81D22E20B9

Q35855727-6F7B0001-7E63-47DB-B5EA-80DC590E27F1

Q35855727-724E0D4B-43CF-4B36-A9AF-CE34D0D024B2

Q35855727-749DB0DC-A041-4345-B3AA-D9453505C2AD

Q35855727-7F867E7A-97A2-4F33-AEF9-A356DD3C0438

P2860

Q35855727-00772691-C844-46EB-8A8E-4D549D0C947C

Q35855727-0D7D1B4F-BD76-40D0-BAFE-40450D5F5C61

Q35855727-15CFE967-A7EE-4E09-91E0-F7F04BD3110F

Q35855727-39A85B06-4EE4-4DDF-82A5-54C008A23662

Q35855727-3E1BCE14-E4EB-4398-B145-268294231CE1

Q35855727-45FABF64-30EA-4532-A21C-9855871DA7E1

Q35855727-4CFE7ABB-FF4E-4141-B180-D1436E19823B

Q35855727-4D303BDE-8183-4DA8-B775-2A908F0B4C47

Q35855727-550B3322-E8C4-453B-A6C4-BB2FA2A51D04

Q35855727-751C401C-8446-4E9E-AFD4-4D3166EDE69E

P304

Q35855727-0779A6B8-ADAE-4652-84D8-AA11380BD64C

P31

Q35855727-6683BDA4-BF2A-4E5E-B7F4-A63851B403BA

P356

Q35855727-878F2C18-DDC2-4C2E-AA8E-18ED04BAFA0E

P407

Q35855727-55A0AC53-4D25-4516-9131-99C1C0E01839

P433

Q35855727-F5A67C0B-6F85-417D-A68C-3455A0AAC816

P478

Q35855727-F4520820-0D2C-4749-BC6D-A541A0C8C6DC

P50

Q35855727-51B0C168-70BA-4A1C-ADCB-572C83DB8873

Q35855727-61865A93-1AFA-441B-8B5E-828714D8D6E8

Q35855727-E40E5E35-70B2-4641-9BBC-148AF9C78762

Q35855727-F3FE48E6-0D3B-45C9-AA5C-63D9B3285555

P577

Q35855727-010F2B24-1FF5-49B3-9E8F-36376482A4B8

P5875

Q35855727-CB5AB708-788E-49BB-8B4D-9030C441C6E6

P698

Q35855727-B78ABB76-9C5B-46EF-8B06-E7976848D8E6

P921

Q35855727-1ECF99A0-5E30-4750-80F7-164D1E57039E

Q35855727-3CD37468-80CD-4F24-B787-3C860D385AE4

P932

Q35855727-B326544A-40BB-4D44-A74B-6F1D2E2D970A

P356

SCITRANSLMED.3002901

P1433

Science Translational Medicine

P1476

A neutralizing human monoclona ...... ys from hendra virus challenge

@en

P2093

Andrew C Hickey

http://www.w3.org/2001/XMLSchema#string

Antony S Dimitrov

http://www.w3.org/2001/XMLSchema#string

Barry Rockx

http://www.w3.org/2001/XMLSchema#string

Christopher C Broder

http://www.w3.org/2001/XMLSchema#string

Dana Scott

http://www.w3.org/2001/XMLSchema#string

Dimiter S Dimitrov

http://www.w3.org/2001/XMLSchema#string

Doug Brining

http://www.w3.org/2001/XMLSchema#string

Joan B Geisbert

http://www.w3.org/2001/XMLSchema#string

Julie Callison

http://www.w3.org/2001/XMLSchema#string

Lianying Yan

http://www.w3.org/2001/XMLSchema#string

P2860

Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus

A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge

Henipavirus and Tioman virus antibodies in pteropodid bats, Madagascar

Two key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virus

Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies.

Hendra and Nipah viruses: different and dangerous.

Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody.

Preparation of recombinant viral glycoproteins for novel and therapeutic antibody discovery.

A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection.

Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection.

P304

105ra103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCITRANSLMED.3002901

http://www.w3.org/2001/XMLSchema#string

P407

P433

105

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Katharine Bossart

Thomas W Geisbert

Friederike Feldmann

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51731815

http://www.w3.org/2001/XMLSchema#string

P698

22013123

http://www.w3.org/2001/XMLSchema#string

P921

P932

3313625

http://www.w3.org/2001/XMLSchema#string